sar425899 glp-1 glucagon dual agonist sanofi Receptor occupancy of glucagon-like peptide 1/glucagon receptor in individuals with type 2 diabetes Focus on Glucagon-like Peptide-1 Target:

These one-page guides will answer your patient's most common questions when starting a GLP-1 RA or SGLT2i medication..

Conventional wisdom says GLP-1 drugs must be taken indefinitely to maintain weight loss

Gastric ultrasound identifies increased residual gastric contents in patients on GLP-1 receptor agonists, showing that shorter drug withholding and fasting times are linked to higher aspiration risk before anesthesia.

A summary of the guidelines for perioperative management of GLP-1 RAs, GIP agonists, & SGLT2 inhibitors in adults.

pooling data for lixisenatide (Adlyxin, Sanofi), liraglutide (Victoza,

The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.